©The Author(s) 2022.
World J Gastroenterol. Jun 14, 2022; 28(22): 2468-2481
Published online Jun 14, 2022. doi: 10.3748/wjg.v28.i22.2468
Published online Jun 14, 2022. doi: 10.3748/wjg.v28.i22.2468
Table 1 Patient characteristics, n (%)
| Patient characteristics | n = 67 |
| Age (yr) | |
| ≤ 60 | 31 (46.3) |
| > 60 | 36 (53.7) |
| Sex | |
| Male | 42 (62.7) |
| Female | 25 (37.3) |
| Tumour location | |
| Head/uncinate | 44 (65.7) |
| Body/tail | 23 (34.3) |
| CA19-9 | |
| < 37 ng/mL | 20 (29.9) |
| ≥ 37 ng/mL | 47 (70.1) |
| AJCC stage (2017) | |
| I | 11 (16.4) |
| II | 27 (40.3) |
| III | 29 (43.3) |
| Tumour differentiation | |
| Highly/moderately | 49 (73.1) |
| Poorly/undifferentiated | 18 (26.9) |
| Surgical margin | |
| Negative | 57 (85.1) |
| Positive | 10 (14.9) |
| Vascular invasion | |
| No | 51 (76.1) |
| Yes | 16 (23.9) |
| Adjuvant chemotherapy | |
| No | 33 (49.3) |
| Yes | 34 (50.7) |
- Citation: Gao JF, Pan Y, Lin XC, Lu FC, Qiu DS, Liu JJ, Huang HG. Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer. World J Gastroenterol 2022; 28(22): 2468-2481
- URL: https://www.wjgnet.com/1007-9327/full/v28/i22/2468.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i22.2468